Superoxide dismutase (SOD) vs placebo
Neonatal mortality · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes neonatal mortality (i.e. within 28 days)№ of participants: 335(2 RCTs) compared with placebo (very low certainty).
1 finding from 1 review
- Superoxide dismutase for bronchopulmonary dysplasia in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.98 [0.57, 1.68]Studies not reportedVery low